Edwards Lifesciences Corp (EW)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 597,000 | 596,300 | 595,700 | 595,000 | 594,400 |
| Total stockholders’ equity | US$ in thousands | 6,650,000 | 5,806,700 | 5,835,900 | 4,574,300 | 4,148,300 |
| Debt-to-equity ratio | 0.09 | 0.10 | 0.10 | 0.13 | 0.14 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $597,000K ÷ $6,650,000K
= 0.09
The debt-to-equity ratio of Edwards Lifesciences Corp has shown a decreasing trend over the past five years, indicating a strengthening financial position in terms of leverage. The ratio decreased from 0.14 in 2019 to 0.09 in 2023. This decline suggests that the company has been reducing its reliance on debt financing in relation to equity, potentially lowering its financial risk and improving its ability to cover debt obligations. A lower debt-to-equity ratio is generally viewed positively by investors and creditors as it signifies a healthier balance sheet structure. Overall, the trend in Edwards Lifesciences Corp's debt-to-equity ratio reflects a positive shift towards a more sustainable and stable financial standing.
Peer comparison
Dec 31, 2023